Literature DB >> 29622713

Uncommon presentation, rare complication and previously undescribed oncologic association of pheochromocytoma; the great masquerader.

David Lawrence1, Kevan Salimian2, Thorsten Leucker3, Seth Martin3.   

Abstract

We describe the case of a 67-year-old man presenting with ventricular tachycardia (VT) and systolic heart failure secondary to a left adrenal phaeochromocytoma. After treatment with amiodarone, the patient's VT resolved. However, his course was complicated by femoral deep venous thrombosis secondary to an incidentally discovered dedifferentiated liposarcoma of the thigh, for which he was prescribed a course of enoxaparin. The patient was discharged with plans for adrenalectomy following achievement of sufficient preoperative heart rate and blood pressure control with alpha-adrenergic receptor blockade, but re-presented to an outside facility in haemorrhagic shock, where he ultimately expired. Autopsy determined his death to be caused by spontaneous haemorrhage of the phaeochromocytoma. Cardiac manifestations, complications and oncological associations of phaeochromocytoma are discussed. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  arrhythmias; endocrine cancer; heart failure; oncology; unwanted effects / adverse reactions

Mesh:

Year:  2018        PMID: 29622713      PMCID: PMC5893977          DOI: 10.1136/bcr-2017-223993

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  9 in total

1.  Adrenal pheochromocytoma remains a frequently overlooked diagnosis.

Authors:  C Y Lo; K Y Lam; M S Wat; K S Lam
Journal:  Am J Surg       Date:  2000-03       Impact factor: 2.565

Review 2.  Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries.

Authors:  Sivabaskari Pasupathy; Tracy Air; Rachel P Dreyer; Rosanna Tavella; John F Beltrame
Journal:  Circulation       Date:  2015-01-13       Impact factor: 29.690

3.  Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979.

Authors:  C M Beard; S G Sheps; L T Kurland; J A Carney; J T Lie
Journal:  Mayo Clin Proc       Date:  1983-12       Impact factor: 7.616

Review 4.  Cardiovascular manifestations of phaeochromocytoma.

Authors:  Aleksander Prejbisz; Jacques W M Lenders; Graeme Eisenhofer; Andrzej Januszewicz
Journal:  J Hypertens       Date:  2011-11       Impact factor: 4.844

Review 5.  Paraganglioma and phaeochromocytoma: from genetics to personalized medicine.

Authors:  Judith Favier; Laurence Amar; Anne-Paule Gimenez-Roqueplo
Journal:  Nat Rev Endocrinol       Date:  2014-11-11       Impact factor: 43.330

6.  Clinical spectrum of pheochromocytoma.

Authors:  Marlon A Guerrero; Jennifer M J Schreinemakers; Menno R Vriens; Insoo Suh; Jimmy Hwang; Wen T Shen; Jessica Gosnell; Orlo H Clark; Quan-Yang Duh
Journal:  J Am Coll Surg       Date:  2009-12       Impact factor: 6.113

7.  Circumstances of discovery of phaeochromocytoma: a retrospective study of 41 consecutive patients.

Authors:  Jean-Philippe Baguet; Laure Hammer; Tânia Longo Mazzuco; Olivier Chabre; Jean-Michel Mallion; Nathalie Sturm; Philippe Chaffanjon
Journal:  Eur J Endocrinol       Date:  2004-05       Impact factor: 6.664

8.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

Review 9.  Catecholamine-induced cardiomyopathy.

Authors:  Thaslim Ahamed Kassim; Douglas D Clarke; Vinh Q Mai; Patrick W Clyde; K M Mohamed Shakir
Journal:  Endocr Pract       Date:  2008-12       Impact factor: 3.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.